{
    "componentChunkName": "component---src-templates-blog-post-js",
    "path": "/posts/ac48b3e2579d11ec961e9fd82c3a773a/",
    "result": {"data":{"allMysqlLists":{"edges":[{"node":{"title":"From a totally new vaccine to a cocktail that fights multiple variants at once, here's how we beat Omicron","status":1,"alt":"A woman in a blue mask sits in a chair against a terracotta wall while a health worker in scrubs injects a needle into her arm","src":"https://live-production.wcms.abc-cdn.net.au/ab3e717f7f9d5a5ff99c928d32848ece","source":"abc","menu":"au","local_src":"","load_img":"","img_url":"https://live-production.wcms.abc-cdn.net.au/ab3e717f7f9d5a5ff99c928d32848ece","href":"https://www.abc.net.au/news/2021-12-08/omicron-vaccine-resistance-and-boosters/100678988","description":"The emergence of a new COVID-19 variant has put scientists and vaccine manufacturers on notice. As the world anxiously waits for answers, this is everything experts are doing to stay ahead of Omicron. ","country":"au","create_time":"2021-12-07T20:39:03.000Z","content":"[\"The United States led the global race to develop a viable vaccine against COVID-19.\\u00a0\", \"But a year after the first shots received emergency approval from federal regulators, new variants of the virus are changing the game.\\u00a0\\u00a0\", \"Omicron, the wildcard variant already detected in multiple US states and more than 30 countries, including Australia,\\u00a0is the latest to emerge.\\u00a0\", \"With its\\u00a0dastardly combination of mutations,\\u00a0scientists fear it may\\u00a0spread quickly and sidestep vaccines.\", \"Governments and companies worldwide are already moving to stop the variant wreaking havoc, with some floating the possibility of variant-specific booster shots.\", \"Here's what's happening so far, and what it could mean for you.\", \"<div class=\\\"head3\\\">The race to update vaccines</div>\", \"One of the biggest questions facing scientists as they scramble to learn more about the Omicron variant is how existing COVID-19 vaccines will perform against it.\\u00a0\", \"\\\"There are three main characteristics that we worry about with viruses like Omicron,\\\" said Dr Celine Gounder, an epidemiologist from the NYU Grossman School of Medicine.\\u00a0\", \"<img src=\\\"https://live-production.wcms.abc-cdn.net.au/9b1fa5c2b20254230dcaf99200dac1b7\\\" class=\\\"abcImg\\\"></img>\", \"<div class=\\\"imgText\\\"> Dr Celine Gounder says that, despite the emergence of Omicron, she's optimistic existing vaccines will keep preventing serious disease.\\u00a0(Supplied:\\u00a0Dr Celine Gounder)</div>\", \"\\\"First of all, is it more infectious or contagious?\\u00a0\", \"\\\"Number two, is it more virulent or less virulent? In other words, does it cause less-severe disease in individuals who are infected?\\u00a0\", \"\\\"And, number three, is it immune-evading? And this is one characteristic of Omicron that is concerning.\\\"\", \"The new variant has around 50 mutations \\u2014\\u00a0more than double its predecessor, Delta \\u2014\\u00a0including many on its spike, the viral protein that vaccines or illness train the body's immune system to fight with antibodies.\", \"Even so, Dr Gounder is optimistic current vaccines will continue to provide some level of protection, especially with the addition of booster shots.\", \"While scientists assess the threat of the new variant, vaccine manufacturers are looking at whether their products may need to be modified.\\u00a0\", \"<div class=\\\"head3\\\">What are vaccine manufacturers doing?\\u00a0</div>\", \"The makers of US-approved vaccines\\u00a0Pfizer-BioNTech, Moderna and Johnson & Johnson, as well as AstraZeneca \\u2014\\u00a0which is widely used in Europe and Australia \\u2014\\u00a0have all begun to study\\u00a0Omicron.\", \"\\\"[We] believe that fully vaccinated individuals will still have a high level of protection against severe disease caused by Omicron,\\\" said a spokesperson for BioNTech, which developed its shot with Pfizer.\", \"\\\"We anticipate that booster vaccination will further increase protection against severe disease and potentially provide protection against disease of any severity.\\\"\", \"In the case of an \\\"escape variant\\\"\\u00a0\\u2014 a\\u00a0dominant strain of the virus that evades the immunity given by vaccines or previous infections \\u2014\\u00a0BioNTech and Pfizer say they can adapt their mRNA vaccine within six weeks and start shipping doses within 100 days.\", \"<img src=\\\"https://live-production.wcms.abc-cdn.net.au/9461f1f07b854cc8eb421ba21705161a\\\" class=\\\"abcImg\\\"></img>\", \"<div class=\\\"imgText\\\"> Several vaccine makers are experimenting with a possible Omicron-specific booster shot.\\u00a0(AP:\\u00a0Aaron Favila)</div>\", \"Similarly, Moderna is developing an Omicron-specific booster version of its mRNA vaccine that could be ready for clinical testing in 60 to 90 days.\", \"\\\"From the beginning, we have said that, as we seek to defeat the pandemic, it is imperative that we are proactive as the virus evolves,\\\" Moderna chief executive\\u00a0Stephane Bancel said in a statement.\", \"The company is also studying two \\\"multivalent\\\" boosters, which are designed to target common mutations seen across multiple variants. Those results are expected in coming weeks.\", \"As well, Johnson & Johnson is pursuing an Omicron-specific version of its one-shot vaccine that, it says, will be progressed as needed.\", \"\\\"We will not be complacent,\\\" the company's global head of research and development, Dr Mathai Mammen, said in a statement.\", \"<div class=\\\"head3\\\">How soon could Omicron boosters be available?</div>\", \"If modified vaccines prove necessary, the White House believes it could make them widely available within a few months.\\u00a0\", \"That includes the time needed to develop and manufacture the doses, as well as obtaining necessary federal approvals.\\u00a0\", \"\\\"We are planning in that scenario not only for supporting the manufacturers through that process if needed, but also for how would we rapidly get shots in arms,\\\" White House coronavirus response coordinator Jeff Zients told a recent briefing.\", \"\\\"And we know how to do that, given the experience we've had the last year, and that is lessons learned about how we deployed the federal pharmacy programs, set up mass-vaccination sites, go to community health centres and rural clinics.\\\"\", \"Australia would still need to make its own decisions on whether to approve new booster shots and how to distribute them.\\u00a0\", \"There are currently no changes to the national guidance in response to Omicron.\", \"<div class=\\\"head3\\\">Boosters, Delta and the long winter ahead</div>\", \"In the US, Delta remains the dominant strain of COVID-19 and is leading a surge of cases going into winter.\", \"The main things people can do to protect themselves \\u2014\\u00a0regardless of variants \\u2014\\u00a0are to get vaccinated, and wear masks indoors and in public places, according to Dr Gounder.\", \"In countries where the option is available, she also recommends bolstering immunity with booster shots, particularly for the elderly and immunocompromised.\", \"\\\"What we've seen with prior immune-evading variants, like the Beta variant, is you could overcome that relative immune evasion by giving a booster dose of the currently available vaccines,\\\" she said.\", \"\\\"With respect to how quickly [or] how often new variants emerge, that is \\u2014 to some degree \\u2014 in our control.\", \"\\\"As long as we allow the virus to spread from person to person, every time it spreads from one person to another, it replicates and it has the opportunity to mutate.\\\"\", \"Since the first cases of Omicron were reported in Botswana and South Africa last month, President Joe Biden has announced a new national strategy to deal with it.\", \"The plan includes encouraging all adults to get vaccine or booster shots as soon as possible, increasing access to at-home rapid tests, and more stringent testing for international travellers.\", \"<img src=\\\"https://live-production.wcms.abc-cdn.net.au/72f313d9f7f5c33fbe32f5bf4d22d280\\\" class=\\\"abcImg\\\"></img>\", \"<div class=\\\"imgText\\\"> Why we hear about some COVID-19 variants more than others</div>\"]","href_hash":"ac48b3e2579d11ec961e9fd82c3a773a"}}]}},"pageContext":{"slug":"ac48b3e2579d11ec961e9fd82c3a773a"}},
    "staticQueryHashes": ["3649515864","764694655"]}